Dr. Ansfield is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4410 Regent St
Madison, WI 53705Phone+1 608-233-9746
Education & Training
MedStar Health/Georgetown-Washington Hospital CenterFellowship, Cardiovascular Disease, 1970 - 1971
University of Wisconsin Hospitals and ClinicsFellowship, Cardiovascular Disease, 1969 - 1970- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1967 - 1969
University of California (San Francisco)Internship, Internal Medicine, 1966 - 1967
University of Wisconsin School of Medicine & Public HealthClass of 1966
Certifications & Licensure
WI State Medical License 1967 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 1 citationsModification in dogs of the systemic and coronary hemodynamic effects of glucagon by sotalolTheodore B. Berndt, Thomas J. Ansfield, Skoda Alfonso, George G. Rowe
American Heart Journal. 1973-05-01 - Enhancement of cardiovascular effects of glucagon by aminophyllineSkoda Afonso, Charles E. Hansing, Thomas J. Ansfield, Theodore B. Berndt, George G. Rowe
Cardiovascular Research. 1972-05-01 - 7 citationsENHANCEMENT OF CORONARY VASODILATOR ACTION OF NICOTINAMIDE ADENINE DINUCLEOTIDE BY LIDOFLAZINESkoda Afonso, George S. O'brien, Theodore B. Berndt, Thomas J. Ansfield, George G. Rowe
The Journal of Pharmacology and Experimental Therapeutics. 1971-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
